speb/financial-data huggingface dataset:
NSPR balance_sheet (quarterly, 2025-12-31) — Share Issued: 43532281.00
NSPR cash_flow (annual, 2025-12-31) — Stock Based Compensation: 12332000.00
NSPR cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2848000.00
NSPR balance_sheet (annual, 2025-12-31) — Stockholders Equity: 55201000.00
NSPR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 55201000.00
NSPR balance_sheet (annual, 2025-12-31) — Tangible Book Value: 55201000.00
NSPR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 55201000.00
NSPR income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NSPR income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NSPR income_statement (annual, 2025-12-31) — Tax Provision: 63000.00
NSPR income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
NSPR income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
NSPR balance_sheet (annual, 2025-12-31) — Total Assets: 69404000.00
NSPR balance_sheet (quarterly, 2025-12-31) — Total Assets: 69404000.00
NSPR balance_sheet (annual, 2025-12-31) — Total Capitalization: 55201000.00
NSPR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 55201000.00
NSPR balance_sheet (annual, 2025-12-31) — Total Debt: 3290000.00
NSPR balance_sheet (quarterly, 2025-12-31) — Total Debt: 3290000.00
NSPR balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 55201000.00
NSPR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 55201000.00
NSPR income_statement (annual, 2025-12-31) — Total Expenses: 58593000.00
NSPR income_statement (quarterly, 2025-12-31) — Total Expenses: 15233000.00
NSPR balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 14203000.00
NSPR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 14203000.00
NSPR balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 7933000.00
NSPR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 7933000.00
NSPR balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3491000.00
NSPR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3491000.00
NSPR income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -49614000.00
NSPR income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -12084000.00
NSPR cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -359000.00
NSPR cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -181000.00
NSPR balance_sheet (annual, 2025-12-31) — Work In Process: 930000.00
NSPR balance_sheet (quarterly, 2025-12-31) — Work In Process: 930000.00
NSPR balance_sheet (annual, 2025-12-31) — Working Capital: 50759000.00
NSPR balance_sheet (quarterly, 2025-12-31) — Working Capital: 50759000.00
NSPR income_statement (quarterly, 2026-03-31) — +Operating Expense: 14665000.00
NSPR income_statement (quarterly, 2026-03-31) — +Total Revenue: 3398000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1954000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2381000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 359594000.00
NSPR income_statement (quarterly, 2026-03-31) — Basic Average Shares: 83801839.00
NSPR income_statement (quarterly, 2026-03-31) — Basic EPS: -0.16
NSPR cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 8939000.00
NSPR cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -194000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3109000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 11362000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 41570000.00
NSPR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 0.00
NSPR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 14779000.00
NSPR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -12337000.00
NSPR cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 699000.00
NSPR cash_flow (quarterly, 2026-03-31) — Change In Inventory: 360000.00
NSPR cash_flow (quarterly, 2026-03-31) — Change In Payable: -1291000.00
NSPR cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -1291000.00
NSPR cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 96000.00
NSPR cash_flow (quarterly, 2026-03-31) — Change In Receivables: -220000.00
NSPR cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1055000.00
NSPR cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -213000.00
NSPR cash_flow (quarterly, 2026-03-31) — Changes In Cash: 2442000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Common Stock: 4000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 43617000.00
NSPR cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
NSPR income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2711000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 3208000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Current Assets: 48594000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1067000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1067000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 9443000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Defined Pension Benefit: 1185000.00
NSPR cash_flow (quarterly, 2026-03-31) — Depreciation: 149000.00
NSPR cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 149000.00
NSPR cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 149000.00
NSPR income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 83801839.00
NSPR income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.16
NSPR income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -13689000.00
NSPR income_statement (quarterly, 2026-03-31) — EBIT: -13978000.00
NSPR income_statement (quarterly, 2026-03-31) — EBITDA: -13829000.00
NSPR cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -19000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 1369000.00
NSPR cash_flow (quarterly, 2026-03-31) — End Cash Position: 11362000.00
NSPR cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 0.00
NSPR balance_sheet (quarterly, 2026-03-31) — Finished Goods: 543000.00
NSPR cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -12531000.00
NSPR income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 4722000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Gross PPE: 6246000.00
NSPR income_statement (quarterly, 2026-03-31) — Gross Profit: 687000.00
NSPR income_statement (quarterly, 2026-03-31) — Interest Income: 289000.00
NSPR income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 289000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Inventory: 3036000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Invested Capital: 43617000.00
NSPR cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 14779000.00
NSPR cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
NSPR balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 2042000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2042000.00
NSPR cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
NSPR income_statement (quarterly, 2026-03-31) — Net Income: -13689000.00
NSPR income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -13689000.00
NSPR income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -13689000.00
NSPR income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -13689000.00
NSPR income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -13689000.00
NSPR cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -13689000.00
NSPR income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -13689000.00
NSPR income_statement (quarterly, 2026-03-31) — Net Interest Income: 289000.00
NSPR cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 15000000.00
NSPR income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 289000.00
NSPR cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -27000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Net PPE: 6246000.00
NSPR cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -194000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 43617000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1369000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 446000.00
NSPR income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -13829000.00
NSPR income_statement (quarterly, 2026-03-31) — Normalized Income: -13689000.00
NSPR cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -12337000.00
NSPR cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 93000.00
NSPR income_statement (quarterly, 2026-03-31) — Operating Income: -13978000.00
NSPR income_statement (quarterly, 2026-03-31) — Operating Revenue: 3398000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 46838963.00
NSPR income_statement (quarterly, 2026-03-31) — Other Gand A: 4722000.00
NSPR cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -4000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Other Payable: 333000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Other Properties: 6246000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Other Receivables: 407000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 30208000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Payables: 2287000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 5495000.00
NSPR cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: 93000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2881000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1200000.00
NSPR income_statement (quarterly, 2026-03-31) — Pretax Income: -13689000.00
NSPR cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
NSPR cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -194000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1590000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Receivables: 2788000.00
NSPR income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2711000.00
NSPR income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 149000.00
NSPR income_statement (quarterly, 2026-03-31) — Research And Development: 4763000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -315981000.00
NSPR cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 15000000.00
NSPR income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 5180000.00
NSPR income_statement (quarterly, 2026-03-31) — Selling General And Administration: 9902000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Share Issued: 46838963.00
NSPR cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2105000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 43617000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 43617000.00
NSPR income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
NSPR income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
NSPR balance_sheet (quarterly, 2026-03-31) — Total Assets: 56471000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 43617000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Total Debt: 3109000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 43617000.00
NSPR income_statement (quarterly, 2026-03-31) — Total Expenses: 17376000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 12854000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 7877000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3411000.00
NSPR income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -13978000.00
NSPR cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 64000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Work In Process: 903000.00
NSPR balance_sheet (quarterly, 2026-03-31) — Working Capital: 39151000.00
NSRX income_statement (annual, 2022-12-31) — +Operating Expense: 2042000.00
NSRX income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
NSRX balance_sheet (annual, 2022-12-31) — Accounts Payable: 771000.00
NSRX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 7292000.00
NSRX income_statement (annual, 2022-12-31) — Basic Average Shares: 7027725.00
NSRX income_statement (annual, 2022-12-31) — Basic EPS: -0.24
NSRX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 314000.00
NSRX balance_sheet (annual, 2022-12-31) — Capital Stock: 4000.00
NSRX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 154000.00
NSRX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 154000.00
NSRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 1469000.00
NSRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 0.00
NSRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -1536000.00
NSRX cash_flow (annual, 2022-12-31) — Cash From Discontinued Financing Activities: -231000.00
NSRX cash_flow (annual, 2022-12-31) — Cash From Discontinued Investing Activities: -160000.00
NSRX cash_flow (annual, 2022-12-31) — Cash From Discontinued Operating Activities: 325000.00
NSRX cash_flow (annual, 2022-12-31) — Change In Account Payable: 150000.00
NSRX cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 153000.00
NSRX cash_flow (annual, 2022-12-31) — Change In Payable: 150000.00
NSRX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 303000.00
NSRX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 174000.00
NSRX cash_flow (annual, 2022-12-31) — Change In Working Capital: 477000.00
NSRX cash_flow (annual, 2022-12-31) — Changes In Cash: -133000.00
NSRX balance_sheet (annual, 2022-12-31) — Common Stock: 4000.00
NSRX balance_sheet (annual, 2022-12-31) — Common Stock Equity: -2785000.00
NSRX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 345000.00
NSRX balance_sheet (annual, 2022-12-31) — Current Assets: 417000.00
NSRX balance_sheet (annual, 2022-12-31) — Current Debt: 1572000.00
NSRX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1572000.00
NSRX balance_sheet (annual, 2022-12-31) — Current Liabilities: 3202000.00
NSRX income_statement (annual, 2022-12-31) — Diluted Average Shares: 7027725.00
NSRX income_statement (annual, 2022-12-31) — Diluted EPS: -0.24
NSRX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -1711000.00
NSRX income_statement (annual, 2022-12-31) — EBIT: -2134000.00
NSRX income_statement (annual, 2022-12-31) — EBITDA: -2134000.00
NSRX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -10000.00
NSRX cash_flow (annual, 2022-12-31) — End Cash Position: 171000.00
NSRX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1238000.00
NSRX cash_flow (annual, 2022-12-31) — Free Cash Flow: -1211000.00
NSRX cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 88000.00
NSRX income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -88000.00
NSRX income_statement (annual, 2022-12-31) — General And Administrative Expense: 926000.00
NSRX income_statement (annual, 2022-12-31) — Interest Expense: 18000.00
NSRX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 18000.00
NSRX balance_sheet (annual, 2022-12-31) — Invested Capital: -1213000.00
NSRX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -160000.00
NSRX cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1466000.00
NSRX balance_sheet (annual, 2022-12-31) — Net Debt: 1418000.00
NSRX cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 10000.00
NSRX income_statement (annual, 2022-12-31) — Net Income: -1711000.00
NSRX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -1711000.00
NSRX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -2152000.00
NSRX income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 441000.00
NSRX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -1711000.00
NSRX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -2152000.00
NSRX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -2152000.00
NSRX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -1711000.00
NSRX income_statement (annual, 2022-12-31) — Net Interest Income: -18000.00
NSRX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 1466000.00
NSRX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -18000.00
NSRX cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 1466000.00
NSRX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -2785000.00
NSRX income_statement (annual, 2022-12-31) — Normalized EBITDA: -2046000.00
NSRX income_statement (annual, 2022-12-31) — Normalized Income: -2064000.00
NSRX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1211000.00
NSRX cash_flow (annual, 2022-12-31) — Operating Gains Losses: 98000.00
NSRX income_statement (annual, 2022-12-31) — Operating Income: -2042000.00
NSRX income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
NSRX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 9059634.00
NSRX balance_sheet (annual, 2022-12-31) — Other Current Assets: 246000.00
NSRX balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 1572000.00
NSRX balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 514000.00
NSRX income_statement (annual, 2022-12-31) — Other Gand A: 926000.00
NSRX income_statement (annual, 2022-12-31) — Other Income Expense: -92000.00
NSRX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 18000.00
NSRX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -4000.00
NSRX balance_sheet (annual, 2022-12-31) — Payables: 771000.00
NSRX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1116000.00
NSRX income_statement (annual, 2022-12-31) — Pretax Income: -2152000.00
NSRX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 3000.00
NSRX income_statement (annual, 2022-12-31) — Research And Development: 1116000.00
NSRX balance_sheet (annual, 2022-12-31) — Restricted Cash: 17000.00
NSRX balance_sheet (annual, 2022-12-31) — Retained Earnings: -10081000.00
NSRX income_statement (annual, 2022-12-31) — Selling General And Administration: 926000.00
NSRX balance_sheet (annual, 2022-12-31) — Share Issued: 9059634.00
NSRX cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 1466000.00
NSRX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 23000.00
NSRX balance_sheet (annual, 2022-12-31) — Stockholders Equity: -2785000.00
NSRX balance_sheet (annual, 2022-12-31) — Tangible Book Value: -2785000.00
NSRX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
NSRX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
NSRX balance_sheet (annual, 2022-12-31) — Total Assets: 417000.00
NSRX balance_sheet (annual, 2022-12-31) — Total Capitalization: -2785000.00
NSRX balance_sheet (annual, 2022-12-31) — Total Debt: 1572000.00
NSRX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -2785000.00
NSRX income_statement (annual, 2022-12-31) — Total Expenses: 2042000.00
NSRX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3202000.00
NSRX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 0.00
NSRX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
NSRX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -2042000.00
NSRX income_statement (annual, 2022-12-31) — Total Unusual Items: -88000.00
NSRX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -88000.00
NSRX cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 88000.00
NSRX balance_sheet (annual, 2022-12-31) — Working Capital: -2785000.00
NSRX income_statement (annual, 2023-12-31) — +Operating Expense: 1147000.00
NSRX income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
NSRX balance_sheet (annual, 2023-12-31) — Accounts Payable: 655000.00
NSRX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 7316000.00
NSRX income_statement (annual, 2023-12-31) — Basic Average Shares: 6889708.00
NSRX income_statement (annual, 2023-12-31) — Basic EPS: -0.15
NSRX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 171000.00
NSRX balance_sheet (annual, 2023-12-31) — Capital Stock: 19000.00
NSRX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 193000.00
NSRX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 193000.00
NSRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 1055000.00
NSRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 0.00
NSRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -982000.00
NSRX cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: 0.00
NSRX cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: 0.00
NSRX cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: -47000.00
NSRX cash_flow (annual, 2023-12-31) — Change In Account Payable: -116000.00
NSRX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 271000.00
NSRX cash_flow (annual, 2023-12-31) — Change In Interest Payable: 0.00
NSRX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 0.00
NSRX cash_flow (annual, 2023-12-31) — Change In Payable: -116000.00
NSRX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 155000.00
NSRX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 12000.00
NSRX cash_flow (annual, 2023-12-31) — Change In Working Capital: 167000.00
NSRX cash_flow (annual, 2023-12-31) — Changes In Cash: 26000.00
NSRX balance_sheet (annual, 2023-12-31) — Common Stock: 19000.00
NSRX balance_sheet (annual, 2023-12-31) — Common Stock Equity: -3797000.00
NSRX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
NSRX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 616000.00
NSRX balance_sheet (annual, 2023-12-31) — Current Assets: 444000.00
NSRX balance_sheet (annual, 2023-12-31) — Current Debt: 2457000.00
NSRX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2457000.00
NSRX balance_sheet (annual, 2023-12-31) — Current Liabilities: 4241000.00
NSRX income_statement (annual, 2023-12-31) — Diluted Average Shares: 7057820.00
NSRX income_statement (annual, 2023-12-31) — Diluted EPS: -0.20
NSRX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -1051000.00
NSRX income_statement (annual, 2023-12-31) — EBIT: -1147000.00
NSRX income_statement (annual, 2023-12-31) — EBITDA: -1147000.00
NSRX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 13000.00
NSRX cash_flow (annual, 2023-12-31) — End Cash Position: 210000.00
NSRX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 1055000.00
NSRX cash_flow (annual, 2023-12-31) — Free Cash Flow: -1029000.00
NSRX cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -219000.00
NSRX income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 219000.00
NSRX income_statement (annual, 2023-12-31) — General And Administrative Expense: 580000.00
NSRX income_statement (annual, 2023-12-31) — Interest Expense: 49000.00
NSRX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 49000.00
NSRX balance_sheet (annual, 2023-12-31) — Invested Capital: -1340000.00
NSRX cash_flow (annual, 2023-12-31) — Investing Cash Flow: 0.00
NSRX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
NSRX cash_flow (annual, 2023-12-31) — Issuance Of Debt: 1055000.00
NSRX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
NSRX balance_sheet (annual, 2023-12-31) — Net Debt: 2264000.00
NSRX cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -13000.00
NSRX income_statement (annual, 2023-12-31) — Net Income: -1051000.00
NSRX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -1051000.00
NSRX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -1005000.00
NSRX income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -46000.00
NSRX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -1051000.00
NSRX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -1005000.00
NSRX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -1005000.00
NSRX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -1051000.00
NSRX income_statement (annual, 2023-12-31) — Net Interest Income: -49000.00
NSRX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
NSRX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 1055000.00
NSRX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -49000.00
NSRX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
NSRX cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 1055000.00
NSRX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -3797000.00
NSRX balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 0.00
NSRX income_statement (annual, 2023-12-31) — Normalized EBITDA: -1366000.00
NSRX income_statement (annual, 2023-12-31) — Normalized Income: -1224000.00
NSRX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -1029000.00
NSRX cash_flow (annual, 2023-12-31) — Operating Gains Losses: -232000.00
NSRX income_statement (annual, 2023-12-31) — Operating Income: -1147000.00
NSRX income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
NSRX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 9059634.00
NSRX balance_sheet (annual, 2023-12-31) — Other Current Assets: 234000.00
NSRX balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 2457000.00
NSRX balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 513000.00
NSRX income_statement (annual, 2023-12-31) — Other Gand A: 580000.00
NSRX income_statement (annual, 2023-12-31) — Other Income Expense: 191000.00
NSRX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 49000.00
NSRX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -28000.00
NSRX balance_sheet (annual, 2023-12-31) — Payables: 655000.00
NSRX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1271000.00
NSRX income_statement (annual, 2023-12-31) — Pretax Income: -1005000.00
NSRX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
NSRX cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
NSRX income_statement (annual, 2023-12-31) — Research And Development: 567000.00
NSRX balance_sheet (annual, 2023-12-31) — Restricted Cash: 17000.00
NSRX balance_sheet (annual, 2023-12-31) — Retained Earnings: -11132000.00
NSRX income_statement (annual, 2023-12-31) — Selling General And Administration: 580000.00
NSRX balance_sheet (annual, 2023-12-31) — Share Issued: 9059634.00
NSRX cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 1055000.00
NSRX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 39000.00
NSRX balance_sheet (annual, 2023-12-31) — Stockholders Equity: -3797000.00
NSRX balance_sheet (annual, 2023-12-31) — Tangible Book Value: -3797000.00
NSRX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
NSRX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
NSRX balance_sheet (annual, 2023-12-31) — Total Assets: 444000.00
NSRX balance_sheet (annual, 2023-12-31) — Total Capitalization: -3797000.00
NSRX balance_sheet (annual, 2023-12-31) — Total Debt: 2457000.00
NSRX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -3797000.00
NSRX income_statement (annual, 2023-12-31) — Total Expenses: 1147000.00
NSRX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 4241000.00
NSRX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 0.00
NSRX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
NSRX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -1147000.00
NSRX income_statement (annual, 2023-12-31) — Total Other Finance Cost: 49000.00
NSRX income_statement (annual, 2023-12-31) — Total Unusual Items: 219000.00
NSRX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 219000.00
NSRX cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -219000.00
NSRX balance_sheet (annual, 2023-12-31) — Working Capital: -3797000.00
NSRX income_statement (annual, 2024-12-31) — +Operating Expense: 1078000.00
NSRX income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
NSRX balance_sheet (annual, 2024-12-31) — Accounts Payable: 651000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 651000.00
NSRX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 9432000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 9432000.00
NSRX income_statement (annual, 2024-12-31) — Basic Average Shares: 7027725.00
NSRX income_statement (annual, 2024-12-31) — Basic EPS: -0.22
NSRX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 210000.00
NSRX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 0.00
NSRX balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 0.00
NSRX balance_sheet (annual, 2024-12-31) — Capital Stock: 20000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Capital Stock: 20000.00
NSRX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 284000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 284000.00
NSRX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 284000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 284000.00
NSRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 770000.00
NSRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
NSRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -661000.00
NSRX cash_flow (annual, 2024-12-31) — Cash From Discontinued Financing Activities: 0.00
NSRX cash_flow (annual, 2024-12-31) — Cash From Discontinued Investing Activities: 0.00
NSRX cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: -4000.00
NSRX cash_flow (annual, 2024-12-31) — Change In Account Payable: -5000.00
NSRX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 322000.00
NSRX cash_flow (annual, 2024-12-31) — Change In Interest Payable: 0.00
NSRX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 0.00
NSRX cash_flow (annual, 2024-12-31) — Change In Payable: -5000.00
NSRX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 317000.00
NSRX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 88000.00
NSRX cash_flow (annual, 2024-12-31) — Change In Working Capital: 405000.00
NSRX cash_flow (annual, 2024-12-31) — Changes In Cash: 105000.00
NSRX balance_sheet (annual, 2024-12-31) — Common Stock: 20000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Common Stock: 20000.00
NSRX balance_sheet (annual, 2024-12-31) — Common Stock Equity: -3212000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -3212000.00
NSRX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
NSRX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 844000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 844000.00
NSRX balance_sheet (annual, 2024-12-31) — Current Assets: 457000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Current Assets: 457000.00
NSRX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 0.00
NSRX balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 0.00
NSRX balance_sheet (annual, 2024-12-31) — Current Debt: 1802000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Current Debt: 1802000.00
NSRX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1802000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 1802000.00
NSRX balance_sheet (annual, 2024-12-31) — Current Liabilities: 3929000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 3929000.00
NSRX income_statement (annual, 2024-12-31) — Diluted Average Shares: 7027725.00
NSRX income_statement (annual, 2024-12-31) — Diluted EPS: -0.22
NSRX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -1532000.00
NSRX income_statement (annual, 2024-12-31) — EBIT: -1078000.00
NSRX income_statement (annual, 2024-12-31) — EBITDA: -1078000.00
NSRX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -4000.00
NSRX cash_flow (annual, 2024-12-31) — End Cash Position: 311000.00
NSRX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 770000.00
NSRX cash_flow (annual, 2024-12-31) — Free Cash Flow: -665000.00
NSRX cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 443000.00
NSRX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -443000.00
NSRX income_statement (annual, 2024-12-31) — General And Administrative Expense: 743000.00
NSRX balance_sheet (annual, 2024-12-31) — Gross PPE: 0.00
NSRX balance_sheet (quarterly, 2024-12-31) — Gross PPE: 0.00
NSRX income_statement (annual, 2024-12-31) — Interest Expense: 29000.00
NSRX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 29000.00
NSRX balance_sheet (annual, 2024-12-31) — Invested Capital: -1410000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Invested Capital: -1410000.00
NSRX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 0.00
NSRX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
NSRX cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1000000.00
NSRX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
NSRX balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
NSRX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
NSRX balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
NSRX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
NSRX balance_sheet (annual, 2024-12-31) — Net Debt: 1518000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Net Debt: 1518000.00
NSRX cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 4000.00
NSRX income_statement (annual, 2024-12-31) — Net Income: -1532000.00
NSRX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -1532000.00
NSRX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -1552000.00
NSRX income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 20000.00
NSRX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -1532000.00
NSRX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -1552000.00
NSRX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -1552000.00
NSRX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -1532000.00
NSRX income_statement (annual, 2024-12-31) — Net Interest Income: -29000.00
NSRX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
NSRX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 1000000.00
NSRX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -29000.00
NSRX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -230000.00
NSRX balance_sheet (annual, 2024-12-31) — Net PPE: 0.00
NSRX balance_sheet (quarterly, 2024-12-31) — Net PPE: 0.00
NSRX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
NSRX cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 1000000.00
NSRX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -3212000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -3212000.00
NSRX balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 260000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 260000.00
NSRX income_statement (annual, 2024-12-31) — Normalized EBITDA: -635000.00
NSRX income_statement (annual, 2024-12-31) — Normalized Income: -1109000.00
NSRX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -665000.00
NSRX cash_flow (annual, 2024-12-31) — Operating Gains Losses: 447000.00
NSRX income_statement (annual, 2024-12-31) — Operating Income: -1078000.00
NSRX income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
NSRX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 9059634.00
NSRX balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 9059634.00
NSRX balance_sheet (annual, 2024-12-31) — Other Current Assets: 29000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 29000.00
NSRX balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 1802000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 1802000.00
NSRX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 597000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 597000.00
NSRX income_statement (annual, 2024-12-31) — Other Gand A: 743000.00
NSRX income_statement (annual, 2024-12-31) — Other Income Expense: -445000.00
NSRX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 29000.00
NSRX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -2000.00
NSRX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
NSRX balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
NSRX balance_sheet (annual, 2024-12-31) — Payables: 651000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Payables: 651000.00
NSRX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1495000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 1495000.00
NSRX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 35000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 35000.00
NSRX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 117000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 117000.00
NSRX income_statement (annual, 2024-12-31) — Pretax Income: -1552000.00
NSRX cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
NSRX income_statement (annual, 2024-12-31) — Research And Development: 335000.00
NSRX balance_sheet (annual, 2024-12-31) — Restricted Cash: 27000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 27000.00
NSRX balance_sheet (annual, 2024-12-31) — Retained Earnings: -12664000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -12664000.00
NSRX income_statement (annual, 2024-12-31) — Selling General And Administration: 743000.00
NSRX balance_sheet (annual, 2024-12-31) — Share Issued: 9059634.00
NSRX balance_sheet (quarterly, 2024-12-31) — Share Issued: 9059634.00
NSRX cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 1000000.00
NSRX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 10000.00
NSRX balance_sheet (annual, 2024-12-31) — Stockholders Equity: -3212000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -3212000.00
NSRX balance_sheet (annual, 2024-12-31) — Tangible Book Value: -3212000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -3212000.00
NSRX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
NSRX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
NSRX balance_sheet (annual, 2024-12-31) — Total Assets: 717000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Total Assets: 717000.00
NSRX balance_sheet (annual, 2024-12-31) — Total Capitalization: -3212000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -3212000.00
NSRX balance_sheet (annual, 2024-12-31) — Total Debt: 1802000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Total Debt: 1802000.00
NSRX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -3212000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -3212000.00
NSRX income_statement (annual, 2024-12-31) — Total Expenses: 1078000.00
NSRX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3929000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 3929000.00
NSRX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 260000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 260000.00
NSRX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
NSRX balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
NSRX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -1078000.00
NSRX income_statement (annual, 2024-12-31) — Total Other Finance Cost: 29000.00
NSRX income_statement (annual, 2024-12-31) — Total Unusual Items: -443000.00
NSRX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -443000.00
NSRX cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 443000.00
NSRX balance_sheet (annual, 2024-12-31) — Working Capital: -3472000.00
NSRX balance_sheet (quarterly, 2024-12-31) — Working Capital: -3472000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 664000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 9582000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 20000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 203000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 203000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Common Stock: 20000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -4314000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1179000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Current Assets: 291000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Current Debt: 2563000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2563000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 4953000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Invested Capital: -1751000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Net Debt: 2360000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -4314000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 348000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 9059634.00
NSRX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 59000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 2563000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 547000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Payables: 664000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1843000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 29000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -13916000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Share Issued: 9059634.00
NSRX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -4314000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -4314000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Total Assets: 639000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -4314000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Total Debt: 2563000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -4314000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4953000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 348000.00
NSRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
NSRX balance_sheet (quarterly, 2025-06-30) — Working Capital: -4662000.00
NSRX income_statement (annual, 2025-12-31) — +Operating Expense: 4904000.00
NSRX income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
NSRX balance_sheet (annual, 2025-12-31) — Accounts Payable: 829000.00
NSRX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 829000.00
NSRX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 21288000.00
NSRX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 21288000.00
NSRX income_statement (annual, 2025-12-31) — Basic Average Shares: 8010126.00
NSRX income_statement (annual, 2025-12-31) — Basic EPS: -0.72
NSRX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 311000.00
NSRX cash_flow (annual, 2025-12-31) — Capital Expenditure: -14000.00
NSRX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 118000.00
NSRX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 118000.00
NSRX balance_sheet (annual, 2025-12-31) — Capital Stock: 0.00
NSRX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 0.00
NSRX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1237000.00
NSRX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1237000.00
NSRX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4286000.00
NSRX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4286000.00
NSRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 8920000.00
NSRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -3014000.00
NSRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -4862000.00
NSRX cash_flow (annual, 2025-12-31) — Cash From Discontinued Financing Activities: 0.00
NSRX cash_flow (annual, 2025-12-31) — Cash From Discontinued Investing Activities: 0.00
NSRX cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: -56000.00
NSRX cash_flow (annual, 2025-12-31) — Change In Account Payable: 152000.00
NSRX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -231000.00
NSRX cash_flow (annual, 2025-12-31) — Change In Interest Payable: -49000.00
NSRX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -27000.00
NSRX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 12000.00
NSRX cash_flow (annual, 2025-12-31) — Change In Payable: 152000.00
NSRX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -79000.00
NSRX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -370000.00
NSRX cash_flow (annual, 2025-12-31) — Change In Working Capital: -464000.00
NSRX cash_flow (annual, 2025-12-31) — Changes In Cash: 988000.00
NSRX balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
NSRX balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
NSRX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2768000.00
NSRX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2768000.00